Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Scott Krause
Abbott
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
166 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Canberra Hospital/cardiology Department
Garran, Australian Capital Territory, Australia
- Royal Prince Alfred Hospital/department of Cardiology
Camperdown, New South Wales, Australia
- Concord Hospital - Heart Failure Clinic/department of Cardiology
Concord, New South Wales, Australia
- Gosford Hospital
Gosford, New South Wales, Australia
- Liverpool Hospital - Cardiology Research
Liverpool, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Royal North Shore Hospital - Cardiology Department
St Leonards, New South Wales, Australia
- St. George Hospital/cardiology Department
Sydney, New South Wales, Australia
- Royal Brisbane Hospital - Cardiology Department
Herston, Queensland, Australia
- the Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Flinders Medical Centre - Cardiac Research Department
Bedford Park, South Australia, Australia
- Queen Elizabeth Hospital/cardiology Department
Woodville, South Australia, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- Launceston General Hospital/cardiac Research Unit
Launceston, Tasmania, Australia
- Box Hill Hospital - Coronary Care Unit
Box Hill, Victoria, Australia
- St. Vincent'S Hospital - Cardiology Investigational Unit
Fitzroy, Victoria, Australia
- Karinia House/geelong Hospital
Geelong, Victoria, Australia
- Level 2, Cardiology Department/royal Melbourne Hospital
Parkville, Victoria, Australia
- Heart Research Institute/sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
- Rockyview Hospital, Heart Health Institute
Calgary, Alberta, Canada
- University of Calgary
Calgary, Alberta, Canada
- University of Alberta Hospitals
Edmonton, Alberta, Canada
- Neureka Research, Willet Green Niller Centre
Greater Sudbury, Ontario, Canada
- University of Ottawa Health Institute
Ottawa, Ontario, Canada
- Center Hospital University of Sherbrooke
Sherbrooke, Quebec, Canada
- University of Saskatchewan
Saskatoon, Saskatchewan, Canada
- Barzilai Medical Center
Ashkelon, Israel
- Hillel Yaffe Medical Center
Hadera, Israel
- Wolfson Medical Center
Holon, Israel
- Heart Institute, Hadassah Mc
Jerusalem, Israel
- Emms Nazareth Hospital
Nazareth, Israel
- Kaplan Medical Center
Rehovot, Israel
- Sieff Medical Center
Safed, Israel
- Assaf Harofe Medical Center
Zrifin, Israel
- Cardiology, P.C. Research
Birmingham, Alabama, United States
- Cardiovascular Associates/office of Clinical Research
Birmingham, Alabama, United States
- University Alabama at Birmingham
Birmingham, Alabama, United States
- Oracle Research-the Heart Center
Huntsville, Alabama, United States
- Providence Hospital Heart Failure Clinic
Mobile, Alabama, United States
- Arizona Heart Institute
Phoenix, Arizona, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2002
- Primary completion
- —
- Completion
- 31 Dec 2004
- Last update posted
- 15 Dec 2006
- Registered enrollment
- 600
- Registry id
- NCT00048425
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.